Skip to Content
Merck

Key Documents

View All Documentation

Skip To

D146005

Sigma-Aldrich

2,6-Dimethylaniline

99%

Synonym(s):

2,6-Xylidine, 2-Amino-1,3-dimethylbenzene, 2-Amino-m-xylene

Sign Into View Organizational & Contract Pricing

Select a Size

50 MG
CA$545.00

CA$545.00

Please contact Customer Service for Availability
Request a Bulk Order

Select a Size

Change View
50 MG
CA$545.00

About This Item

Linear Formula:
(CH3)2C6H3NH2
CAS Number:
87-62-7
Molecular Weight:
121.18
Beilstein:
636332
EC Number:
201-758-7
MDL number:
MFCD00007747
UNSPSC Code:
12352100
PubChem Substance ID:
24893446
NACRES:
NA.22

CA$545.00

Please contact Customer Service for Availability
Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

vapor pressure

<0.01 mmHg ( 20 °C)

Quality Level

200

Assay

99%

form

liquid

refractive index

n20/D 1.560 (lit.)

bp

214 °C/739 mmHg (lit.)

mp

10-12 °C (lit.)

density

0.984 g/mL at 25 °C (lit.)

SMILES string

Cc1cccc(C)c1N

InChI

1S/C8H11N/c1-6-4-3-5-7(2)8(6)9/h3-5H,9H2,1-2H3

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
1724088Y0001702Y0001708
Zanamivir &#8805;98% (HPLC)

SML0492

Zanamivir

Zanamivir United States Pharmacopeia (USP) Reference Standard

1724088

Zanamivir

Zanamivir for assay European Pharmacopoeia (EP) Reference Standard

Y0001702

Zanamivir for assay

Zanamivir for system suitability European Pharmacopoeia (EP) Reference Standard

Y0001708

Zanamivir for system suitability

assay

≥98% (HPLC)

assay

-

assay

-

assay

-

form

powder

form

-

form

-

form

-

Quality Level

100

Quality Level

-

Quality Level

-

Quality Level

-

storage temp.

room temp

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

solubility

H2O: 10 mg/mL, clear

solubility

-

solubility

-

solubility

-

color

white to beige

color

-

color

-

color

-

Application

2,6-Dimethylaniline can react with:
  • 1-Naphthaldehyde to form an intermediate, bis(4-amino-3,5-dimethylphenyl)naphthylmethane (BADN) to further form bis(4-maleimido-3,5-dimethylphenyl)naphthylmethane (BMDN) by reacting with maleic anhydride, acetic anhydride and sodium acetate.[1]
  • n-Butyllithium to form lithium 2,6-dimethylanilide, which can be utilized to form various RhII anilide complexes.[2]

Signal Word

Warning

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Carc. 2 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 3

Flash Point(F)

195.8 °F - closed cup

Flash Point(C)

91 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    STBJ8115
    STBJ3534
    STBG8290
    STBH6422
    STBH2708

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Zanamivir
    Waghorn S L and Goa K L
    Drugs, 55(5), 721-725 (1998)
    Emi Takashita et al.
    Antimicrobial agents and chemotherapy, 59(5), 2607-2617 (2015-02-19)
    Between September 2013 and July 2014, 2,482 influenza 2009 pandemic A(H1N1) [A(H1N1)pdm09] viruses were screened in Japan for the H275Y substitution in their neuraminidase (NA) protein, which confers cross-resistance to oseltamivir and peramivir. We found that a large cluster of
    Benjamin O Fulton et al.
    Journal of virology, 89(23), 12226-12231 (2015-09-25)
    Influenza B virus is a human pathogen responsible for significant health and economic burden. Research into this pathogen has been limited by the lack of reporter viruses. Here we describe the development of both a replication-competent fluorescent influenza B reporter
    Carl J Heneghan et al.
    BMJ (Clinical research ed.), 348, g2547-g2547 (2014-05-09)
    To describe the potential benefits and harms of zanamivir. Systematic review of clinical study reports of randomised placebo controlled trials and regulatory information Clinical study reports, trial registries, electronic databases, regulatory archives, and correspondence with manufacturers. Randomised placebo controlled trials
    Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Javier Magano
    Chemical reviews, 109(9), 4398-4438 (2009-06-23)
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service